Biomarkers and Imaging

Digital Innovation

Regional Leadership

• Understanding how and why Asians develop dementia, including by studying perfusion
  and blood brain barrier changes in conjunction with advanced multi-omics and
  imaging-based analytical approaches.​

• Developing accurate, scalable and customisable digital tools to gamify the assessment of cognition and facilitate early interventions.​

• Studying novel drugs and repurposed drugs to treat cognitive diseases.

• We have uncovered Asian populations’ unique dementia biology and risks, addressing this
  gap in knowledge.​

• Our AI-powered screening tool, ReCognAIze, detects mild cognitive impairment – the early
  stage before dementia – efficiently and affordably.​

• We lead impactful research collaborations across Southeast Asia, including via the SEACURE Consortium to harmonise research standards and drive policy.​
  

Click here to find out more about Dementia Research Centre (Singapore).

ReCognAIze uses neuroscientific games to identify early signs of cognitive impairment in just 15 minutes.